```html

Post‑menopausal Bleeding

What is Post‑menopausal bleeding?

Post‑menopausal bleeding (PMB) is any vaginal bleeding that occurs after a woman has gone 12 consecutive months without a menstrual period, indicating that she has entered menopause. While occasional spotting can be benign, any unexpected bleeding after menopause should be taken seriously because it can be a sign of underlying pathology, including malignancy.

According to the Mayo Clinic, PMB is reported by about 5 % of menopausal women each year. The key to appropriate management is a prompt, systematic evaluation to determine the cause and initiate treatment.

Common Causes

PMB can arise from a wide spectrum of conditions, from harmless hormonal fluctuations to potentially life‑threatening cancers. The most frequent causes include:

• Endometrial atrophy – thinning of the uterine lining, the most common benign cause.
• Endometrial polyps – localized growths that can bleed intermittently.
• Hormone therapy (HT) – especially estrogen‑only or improperly balanced estrogen/progestin regimens.
• Uterine (endometrial) hyperplasia – proliferation of the lining that may be precancerous.
• Endometrial cancer – the most serious cause; accounts for ~10 % of PMB cases.
• Cervical cancer or cervical dysplasia – especially in women who have not been regularly screened.
• Uterine (submucosal) fibroids – benign muscle tumors that can degenerate and bleed.
• Coagulopathies & anticoagulant medication – clotting disorders or drugs such as warfarin, DOACs, aspirin.
• Vaginal atrophy (genitourinary syndrome of menopause) – dryness and micro‑tears leading to spotting.
• Rare causes – such as uterine sarcoma, tubo‑ovarian abscess, or metastatic disease.

Associated Symptoms

Other signs that often accompany PMB can help narrow the differential diagnosis:

• Painful or crampy abdominal sensations
• Pelvic pressure or a feeling of fullness
• Unusual vaginal discharge (clear, pink, or foul‑smelling)
• Hot flashes, night sweats, or other menopausal symptoms that may suggest hormonal imbalance
• Unexplained weight loss or fatigue (possible red flags for malignancy)
• Urinary symptoms such as urgency or burning, which may indicate a concurrent infection

When to See a Doctor

Because PMB can be a symptom of serious disease, the threshold for seeking care is low. Contact a health‑care professional promptly if you experience any of the following:

• Any amount of vaginal bleeding after menopause, even spotting
• Bleeding that recurs after a period of being symptom‑free
• Heavy, clotted, or prolonged bleeding (lasting more than a few days)
• Accompanying pelvic pain, pressure, or a mass that you can feel
• Unexplained weight loss, fatigue, or night sweats
• History of endometrial hyperplasia, polyps, or cancer

If you are on hormone therapy, call your prescriber right away—dose adjustments may be required.

Diagnosis

Evaluation of PMB follows a step‑wise algorithm aimed at ruling out cancer first and then identifying benign causes.

1. Medical History & Physical Exam

• Detailed menstrual and bleeding history (onset, duration, amount, pattern)
• Medication review (especially hormones, anticoagulants, tamoxifen)
• Personal and family history of gynecologic cancers
• Pelvic examination to assess the cervix, vagina, uterus, and adnexa

2. Laboratory Tests

• Transvaginal ultrasound (TVUS) – first‑line imaging; measures endometrial thickness. In post‑menopausal women, a thickness ≤ 4 mm is usually considered reassuring (CDC).
• Endometrial biopsy – performed if TVUS shows thickness > 4 mm, if an endometrial polyp is visualized, or if risk factors for cancer exist.
• Optional: Hysteroscopy with directed biopsy for more precise sampling.
• Blood work (CBC, coagulation profile) if bleeding is heavy or anticoagulants are used.

3. Additional Imaging (if needed)

• Saline infusion sonohysterography – improves detection of polyps or submucosal fibroids.
• MRI or CT scan – reserved for suspected myometrial invasion or extra‑uterine disease.

4. Pathology

Biopsy specimens are examined for hyperplasia, atypia, or carcinoma. The pathology report guides further treatment, ranging from simple polypectomy to oncologic surgery.

Treatment Options

Treatment is individualized based on the underlying cause, severity of bleeding, patient age, comorbidities, and personal preferences.

Benign Causes

• Endometrial atrophy – usually resolves after a short course of low‑dose vaginal estrogen (e.g., estradiol cream) or a systemic estrogen‑progestin combo if not contraindicated.
• Endometrial polyps – office‑based hysteroscopic polypectomy; most are removed in an outpatient setting.
• Uterine fibroids – options include:
  • Uterine artery embolization (UAE)
  • Myomectomy (removal of fibroids)
  • MRI‑guided focused ultrasound
• Hormone therapy adjustments – switch from estrogen‑only to combined therapy or reduce dose under supervision.
• Vaginal atrophy – regular use of moisturizers and low‑dose vaginal estrogen; avoid irritants such as scented soaps.
• Coagulopathy management – review and possibly adjust anticoagulant dosing; use of vitamin K (if warfarin) or temporary discontinuation under physician guidance.

Cancer & Pre‑cancer

• Endometrial hyperplasia with atypia – high‑dose progestin therapy (oral medroxyprogesterone acetate 10‑20 mg daily) or hysterectomy depending on age and fertility desire.
• Endometrial cancer – standard treatment includes total hysterectomy with bilateral salpingo‑oophorectomy; adjuvant radiation or chemotherapy is added based on stage (NIH/NCI).
• Cervical cancer – managed according to FIGO stage: conization, trachelectomy, hysterectomy, radiation, or chemoradiation.

Supportive & Home Care

• Maintain a bleeding diary (date, amount, associated symptoms) to share with your clinician.
• Stay hydrated and use panty liners rather than tampons to reduce infection risk.
• Over‑the‑counter pain relievers (acetaminophen or ibuprofen) can alleviate cramping, unless contraindicated.

Prevention Tips

While some causes of PMB (e.g., aging) cannot be prevented, several strategies can lower risk:

• Adhere to routine cervical and pelvic cancer screening (Pap smear, HPV testing, and, if indicated, endometrial cancer risk assessment).
• Use the lowest effective dose of hormone therapy for the shortest duration necessary; discuss alternatives such as non‑hormonal vasomotor symptom treatments.
• Maintain a healthy weight – obesity is a known risk factor for endometrial hyperplasia and cancer.
• Exercise regularly (≥150 minutes of moderate activity per week) to improve hormonal balance.
• Avoid smoking; tobacco increases the risk of many gynecologic cancers.
• Manage diabetes and hypertension, both of which are linked with higher endometrial cancer risk.
• If you take anticoagulants, have regular INR checks (for warfarin) and discuss bleeding risk with your provider.

Emergency Warning Signs

Key Takeaways

• Any vaginal bleeding after menopause warrants medical evaluation.
• Common benign causes include atrophic endometrium and polyps; however, endometrial cancer must always be ruled out.
• Diagnosis relies on a pelvic exam, transvaginal ultrasound, and usually an endometrial biopsy.
• Treatment ranges from simple hormonal adjustments to surgical management depending on the underlying condition.
• Early detection and adherence to screening guidelines are the most effective prevention strategies.

For personalized advice, schedule an appointment with your gynecologist or primary‑care provider. Prompt evaluation not only clarifies the cause but also improves outcomes when serious disease is identified early.

```